Phase 1/1b Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia
Phase of Trial: Phase I
Latest Information Update: 12 Apr 2019
Price : $35 *
At a glance
- Drugs Minnelide (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions
- 08 Apr 2019 Status changed from not yet recruiting to recruiting.
- 18 Mar 2019 Planned End Date changed from 1 Feb 2022 to 1 Jun 2022.
- 18 Mar 2019 Planned primary completion date changed from 1 Feb 2021 to 1 Jun 2021.